“We will continue to focus on growing our core businesses, invest in future growth drivers and work towards greater integration of sustainability in our businesses,’’ G.V. Prasad, co...

Private sector lender Kotak Mahindra Bank on Friday reported a 30.79 per cent jump in its consolidated December quarter net profit at Rs 3,402.74 crore, helped by an all-round performance across subsi...

India has added two new vaccines and an early-use anti-viral drug to its armoury to fight Covid-19, all three products based on core technologies developed in the US but produced in India. The Centra...

Dr Reddy’s Laboratories (DRL) on Tuesday disappointed the Street as it reported a 36 per cent drop in net profit for the first quarter ended June 30.  The Hyderabad-based pharma major also...

Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. P...

Dr Reddy’s Laboratories expects Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks. “We expect to get the approval in the next few weeks...

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma and Dr Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out w...

Public health has been compromised by the pandemic. The health of pharmaceutical companies is under threat too, but from a different kind of source. The Indian pharmaceutical company, Lupin, is the la...

...

A raft of measures adopted by the US government to enhance the availability of drugs are impacting the margins of the Indian companies.Hyderabad-based Dr Reddy’s Laboratories (DRL) has said it expec...